As the tumor progressed, patients with more advanced tumor grades tended to express higher mRNA expression of CBX3 and CBX4 but lower mRNA expression of CBX1, CBX5, CBX6, and CBX7 (Figure 8). Here, CBX3 is linked to neoplasm.